What role does CYP2D6 play in sleep?

CYP2D6 is a key phase I drug-metabolizing enzyme that breaks down many medications, including those that can affect sleep (e.g., certain antidepressants, antipsychotics, beta-blockers, and opioids). Genetic variants in CYP2D6 result in different metabolizer phenotypes (poor, intermediate, normal, ultrarapid). These can indirectly influence sleep quality by altering drug efficacy or side effects. For instance, poor metabolizers of antidepressants like amitriptyline may experience higher blood levels, leading to increased sedation or insomnia. However, there is no strong evidence that CYP2D6 directly regulates sleep physiology. Associations are mostly indirect and medication-dependent. Direct genetic studies linking CYP2D6 to sleep parameters are scarce and inconsistent. Thus, clinical relevance for healthy individuals not taking relevant medications is low. Caution is warranted when DTC tests claim a direct link between CYP2D6 and sleep – such claims are often overstated.